On June 11, 2025, Astrana Health, Inc. held its Annual Meeting where stockholders approved the Amended and Restated 2024 Equity Incentive Plan, increasing shares by 2,000,000 and extending the plan to 2035. The meeting also elected nine directors and ratified Ernst & Young LLP as the independent accounting firm for 2025.